Deng, S., Krutilina, R. I., Wang, Q., Lin, Z., Parke, D. N., Playa, H. C., . . . Li, W. (2019). An orally available tubulin inhibitor, VERU-111, suppresses triple-negative breast cancer tumor growth and metastasis and bypasses taxane resistance. Mol Cancer Ther.

Deng, Shanshan, et al. "An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance." Mol Cancer Ther 2019.

Deng, Shanshan, et al. "An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance." Mol Cancer Ther 2019.